An experimental COVID-19 vaccine in development by Seattle-based HDT Bio will enter early-stage clinical trials in the U.S., the company announced yesterday after the U.S. Food and Drug ...

SOLON, Ohio, May 18, 2021 (GLOBE NEWSWIRE) -- HDT Global (“HDT” or the “Company”), the leading manufacturer of highly engineered, mission-capable infrastructure solutions across defense ...